Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12611001043921
ACTRN12611001043921
Not yet recruiting
未知

Evaluation of a tool to predict diabetes' technology usage in children and adolescents using, or about to commence, continuous subcutaneous insulin infusion (CSII) for type 1 diabetes mellitus.

The Royal Childrens Hospital0 sites100 target enrollmentOctober 5, 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsType 1 diabetes mellitusMetabolic and Endocrine - Diabetes

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 1 diabetes mellitus
Sponsor
The Royal Childrens Hospital
Enrollment
100
Status
Not yet recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 5, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
The Royal Childrens Hospital

Eligibility Criteria

Inclusion Criteria

  • •Inclusion Criteria
  • •Patients will be considered eligible if they are :
  • •\-Over the age of 8yrs
  • •\-Have a diagnosis of Type 1 Diabetes Mellitus
  • •\-Have been using a Medtronic insulin pump compatible with the MiniLink CGM device for \>6mths (CGM arm of study)
  • •\-Home computer with e\-mail access
  • •\-English language comprehension

Exclusion Criteria

  • •Exclusion Criteria
  • •\-Previous self\-initiated use of a continuous glucose monitoring system (this does not exclude clinician initiated previous short term use of one sensor to elucidate glycaemic patterns)
  • •\-Concurrent dermatological disorder e.g. keloid propensity or previous documented hypersensitivity to medical adhesives
  • •\-Impaired vision such that the user would be unable to read the CGM data
  • •\-Other medical condition or use of a medication that in the judgement of the investigator could affect wearing of a CGM sensor on a daily basis
  • •\-Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
urinary exosomal microRNA marker for progressive diabetic nephropathy
KCT0003573Gachon University Gil Medical Center270
Recruiting
Not Applicable
Free Screening camp for Diabetes mellitus and cardiovascular/stroke
CTRI/2012/08/002879SRM University300
Active, not recruiting
Not Applicable
An evaluation of different devices to detect diabetic neuropathy in feet of diabetic patientsDiabetic neuropathyNutritional, Metabolic, Endocrine
ISRCTN85524728orth Cumbria Integrated Care NHS Foundation Trust139
Not yet recruiting
Phase 3
Developing a hospital based electronic diabetes diary for diabetes management
CTRI/2023/03/051077Self
Completed
Not Applicable
Evaluation of a Prototype Diabetes Management System Applied to Insulin Initiation and TitrationType II Diabetes
NCT01698528Joslin Diabetes Center40